Mizuho lowered the firm’s price target on Haemonetics (HAE) to $90 from $115 and keeps an Outperform rating on the shares post the earnings ...

BofA analyst Craig Bijou downgraded Haemonetics (HAE) to Underperform from Neutral with a price target of $68, down from $95, after Q3 revenue ...

(RTTNews) - Haemonetics Corporation (HAE), a provider in medical technology focused on advancing patient outcomes, Tuesday announced that it has finalized the sale of its whole blood assets to GVS ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...

Haemonetics (NYSE:HAE) announced today that it has completed its previously announced sale of its whole blood assets to GVS S.p.A. The sale has a total cash consideration of up to $67.8 million ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...

Haemonetics Corporation provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. The company’s portfolio of ...

You may often notice blank icons on your desktop or folders or incorrect images on your Windows 11 device. These are broken icons in Windows 11/10, and we have just the right solutions for you to ...

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma ...